For 2025, Quest Diagnostics expects revenues between $10.7 billion and $10.85 billion, reported EPS in the range of $8.34 to $8.59, and adjusted EPS between $9.55 and $9.80.

Cigna said its medical loss ratio was 87.9% in Q4 2024, compared to 82.2% in the prior-year quarter. For the full-year 2024, MLR was 83.2%, which was still higher compared to the 81.3% its insurance ...

According to LCH Investments, over 200 hedge funds are Tiger Cubs, funds started by former employees of Tiger Management, the ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

The healthcare industry is undergoing rapid transformation, driven by advancements in technology, artificial intelligence, ...

Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target ...

After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...

HCA Healthcare, Inc. HCA reported fourth-quarter 2024 adjusted earnings per share (EPS) of $6.22, which outpaced the Zacks ...

Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, expectations were $3.8. Operator: Ladies and gentlemen, thank you for ...

Analysis and insights for driving a rapid transition to net-zero while building resilience to physical climate impacts ...